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Epigenetic regulation of lineage-specific genes is
important for the differentiation and function of
T cells. Ten-eleven translocation (Tet) proteins cata-
lyze 5-methylcytosine (5mC) conversion to 5-hydrox-
ymethylcytosine (5hmC) to mediate DNA demethyla-
tion. However, the roles of Tet proteins in the immune
response are unknown. Here, we characterized the
genome-wide distribution of 5hmC in CD4+ T cells
and found that 5hmC marks putative regulatory ele-
ments in signature genes associated with effector
cell differentiation. Moreover, Tet2 protein was re-
cruited to 5hmC-containing regions, dependent on
lineage-specific transcription factors. Deletion of
Tet2 in T cells decreased their cytokine expression,
associated with reduced p300 recruitment. In vivo,
Tet2 plays a critical role in the control of cytokine
gene expression in autoimmune disease. Collec-
tively, our findings suggest that Tet2 promotes DNA
demethylation and activation of cytokine gene
expression in T cells.
INTRODUCTION
Upon activation by antigens, naive CD4+ T cells differentiate into
one of several lineages of helper T (Th) cells, including Th1, Th2,
Th17, and iTreg cells, defined by their patterns of cytokine pro-
duction and immune function (Zhu et al., 2010). Th cell differenti-
ation depends on the complex network of cytokine signaling
imposed on lineage-specific transcription factors (Kanno et al.,
2012). In addition to transcription factors, growing evidence
shows that epigenetic mechanisms are crucial for controlling
Th cell differentiation (Kanno et al., 2012). Wei et al. (2009) re-
ported that histone modifications on the lineage-specific genes
correlate with gene expression in Th cell differentiation. More-
over, we previously reported the recruitment of histone acetyl-transferase (p300) and H3K27 demethylase (JMJD3) in the Il17a
and Il17f loci in a Th17-cell-specific manner (Wang et al., 2012).
Together, these findings suggest that histone modification is an
important mechanism for Th cell differentiation.
DNA methylation at the 5-position of cytosine (5-methylcyto-
sine [5mC]) is one of the key epigenetic mechanisms in develop-
ment and gene regulation (Bird, 2002), and the alterations in DNA
methylation patterns have been implicated in various diseases
(Robertson, 2005). The 5-hydroxymethylcytosine (5hmC) was
first identified in the T-even bacteriophage and was later found
in several tissues (Shen andZhang, 2013). 5hmCexists inmouse,
bovine, and rabbit zygotes as well as mouse embryonic stem
cells and accumulates specifically in the paternal pronucleus
coinciding with a reduction in 5mC (Shen and Zhang, 2013),
implying a potential biological function of 5hmC and a role of
DNAdemethylation in early development. Furthermore, Tsagara-
tou et al. reported that the pattern of 5hmC modification dynam-
ically changes in Th1 and Th2 differentiation, as well as thymic T
cell development (Tsagaratou et al., 2014). Recently, several
studies identified the Ten-Eleven-Translocation (TET) proteins
TET1, TET2, and TET3 as a new family of a-ketoglutarate and
Fe2+-dependent enzymes that alter the methylation status of
DNA by converting 5mC into 5hmC (Pastor et al., 2013). Func-
tional analyses using Tet-deficient cells have demonstrated their
crucial roles in diverse biological processes (Pastor et al., 2013).
Although it is becoming increasingly clear that Tet-mediated 5mC
oxidation at functional genomic elements is physiologically an
important epigenetic process in mammals, the roles of 5hmC
and Tet proteins in the immune system remain to be understood.
Here, we generated genome-widemaps of 5hmC in various Th
cells and found that 5hmC exists at putative regulatory elements
of lineage-specific genes in appropriate Th cells. Tet2 was asso-
ciated with 5hmC-containing regions, and deletion of Tet2 in-
hibited cytokine expression by Th1 and Th17 cells, resulting in
reduction of 5hmC and key transcription factors binding. Finally,
we confirmed Tet2 function in regulating the cytokines expres-
sion in vivo. Collectively, our findings prove that Tet-mediated
active DNA demethylation is an essential epigenetic mechanism
for regulation of Th cell function.Immunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc. 613
RESULTS
Genome-wide Distribution of 5hmC in CD4+ T Cells
To study the role of DNA demethylation and particularly 5hmC
during CD4+ T-cell-mediated immune responses, we conducted
global mapping of 5hmC via DNA immunoprecipitation coupled
with high-throughput sequencing (DIP-seq) (Ku et al., 2011). As a
control, 5mC was analyzed in the same manner. We assessed
these modifications in five types of CD4+ T cells: freshly isolated
CD4+CD25CD44loCD62Lhi (naive) T cells and naive CD4+
T cells cultured under Th1, Th2, Th17, and TGF-b-induced
Treg (iTreg) cell differentiation conditions. The appropriate polar-
ization of each Th cell subset was confirmed by intracellular
staining as well as qPCR. We found enrichment of lineage signa-
ture genes in polarized Th cells (Figure S1A). Furthermore, we
observed approximately 90% of cells expressing lineage-spe-
cific transcription factors in polarized Th cells, although the
percentages of signature cytokine-producing cells varied from
7% (Th2) to 50% (Th1 and Th17) under various conditions (Fig-
ure S1B). Immunoprecipitated samples were amplified and sub-
jected to Illumina sequencing. A total of 172 million short reads
from all samples were aligned onto the mouse genome (mm9
Build 37 assembled by NCBI). In all Th cell subsets, we identified
372,892 5hmC-occupied peaks and 260,315 5mC-occupied
peaks (Table S1). To determine whether our sequencing depth
can cover the size of the 5mC and 5hmC libraries, we performed
a scaling analysis. Randomly sampled fractions of reads from
each sample were subjected to peak identification via the SICER
program (Zang et al., 2009). We found that about 15 or 6 million
reads were sufficient to identify most of peaks for 5mC or 5hmC
samples, respectively (Figure S1C). Therefore, our sequencing
depth was able to cover the size of all libraries. We then analyzed
the distribution of these peaks in themouse genome in four kinds
of regions: promoter (1 kb upstream and downstream of tran-
scription start site), exon, intron, and intergenic, according to
the annotation of ‘‘known genes’’ from the UCSC Genome
Browser (Kent et al., 2002). As shown in Figure 1A and Table
S1, each Th cell subset displayed similar patterns of 5hmC and
5mC distribution. The majority of 5hmC- and 5mC-associated
regions were found in introns and intergenic regions, ranging
from 39% to 57%, suggesting that they might potentially func-
tion in enhancers. In contrast, only around 4% of 5hmC- and
5mC-occupied peaks were localized to promoters and less
than 7% in exons (Figure 1A and Table S1), slightly more than
the presence of these two regions in the whole mouse genome
(Table S1).
It is unclear whether 5hmC and 5mC colocalize in the same
genomic regions during Th cell differentiation or function inde-
pendently. We searched for regions with binary marks of both
5hmC and 5mC. 17%–23% of 5hmC-occupied regions in all
Th cell subsets share both marks (Figure 1B and Table S2), indi-
cating that a potentially active DNA demethylation process
occurred in these regions. However, the majority of conversion
from 5mC to 5hmC has been maintained in Th cell subsets.
We next analyzed the distribution of 5hmC and 5mC within
gene bodies and 5 kb regions 50 and 30 of them. Although similar
amounts and chromosomal distribution of 5mC were found in all
Th cell subsets, the highest amounts of 5hmC in extended genic
regions were found in naive T cells (Figure 1C). Moreover, this614 Immunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc.analysis also revealed the depletion of 5hmC and 5mC islands
from regions proximal to the transcription start sites (TSSs) (Fig-
ure 1C), consistent with the observation that only a minority of
the 5hmC and 5mC islands were located in promoter regions
(Figure 1A).
In mammals, the majority of CpG dinucleotides are methyl-
ated, whereas unmethylated CpGs are found primarily in those
regions of DNA with relatively high density of CpG, so-called
CpG islands (CpGIs) (Bird, 1986). We therefore analyzed the
distribution of 5hmC and 5mC among CpGIs. Our results
showed that 5hmC was depleted from the centers of CpGIs in
all Th cell subsets, whereas 5mC was depleted only at the re-
gions upstream and downstream of the centers of CpGIs (Fig-
ure 1D). Similarly, naive T cells have the highest amounts of
5hmC in CpGIs, suggesting that the change in 5hmC around
TSSs and CpGIs might play a critical role during Th cell
differentiation.
5hmC Associates with Lineage-Specific Signature
Genes
We next examined whether 5hmC and 5mC presented in line-
age-specific genes in each Th cell subset. First, we assessed
5hmC and 5mC patterns in Ifng, Il4, and Il17 cytokine genes,
which serve as the defining lineage markers for Th1, Th2, and
Th17 cells, respectively. As shown in Figure 2A, 5hmC was
strongly associated with Ifng, Il4, and Il17, particularly in some
of the evolutionarily conserved non-coding sequences (CNSs)
and some promoter regions. Furthermore, we confirmed the dis-
tribution of 5hmCand 5mC in naive, Th1, and Th17 cells by qPCR
after immunoprecipitation of 5hmC or 5mC. Consistent with
sequencing analysis, the CNS(6) at Ifng, known as an enhancer
(Hatton et al., 2006), was highly hydroxymethylated in Th1 cells
but hypermethylated in other Th cells (Figure S2A). Similarly,
the CNS2 Il17a and Il17f promoters of the Il17 locus were
strongly hydroxymethylated in Th17 cells but were hypermethy-
lated in other Th cells (Figure S2B). In addition to lineage-specific
cytokines, we also analyzed Il10, which is expressed by virtually
every Th cell subset (Ouyang et al., 2011). As expected, 5hmC
was closely marked with some CNSs of Il10 in Th1, Th2, and
Th17 cells and naive T cells showed strong 5mC peaks in these
regions (Figures 2A and S2C). On the other hand, we could not
detect substantial IL-10 production or augmented 5hmC signals
in iTreg cells (Figure 2A and data not shown). It was also obvious
that many 5hmC peaks were shared by several lineages, while
some lineage-specific peaks were associated with the promoter
and CNS regions of lineage-specific genes such as Ifng, Il17a,
and Il17f (Table S3). As we mentioned above, cells cultured
with in vitro polarized conditions are a heterogeneous population
regarding cytokine production. To assess whether the existence
of non-cytokine-producing cells affect the results of 5hmCmap-
ping, we used cytokine gene reporter mice (Ifngfyp, Il4gfp, and
Il17fCreRosa26yfp) to purify fully polarized Th cells. DIP-PCR anal-
ysis revealed that DNA hydroxymethylation on signature genes
was very similar before and after cell sorting (Figure S3).
Lineage-specific transcription factors such as T-bet, GATA3,
RORgt, and Foxp3 are well known asmaster regulators essential
for development and function of Th1, Th2, Th17, and Treg cells,
respectively. Therefore, we next examined the distribution of
5hmC and 5mC in genes encoding these key transcription
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Figure 1. Comparison of Genome-wide 5hmC and 5mC Distribution in Each T Cell Subset
(A) The distribution of 5hmC and 5mCmodifications was analyzed on the basis of location: promoter (within 1 kb upstream from the transcription start site), exon,
intron, and intergenic regions.
(B) The bar graph showing the percentage of peaks uniquely associated with just 5hmC or both 5hmC and 5mC.
(C) The normalized tag density profiles for 5hmC (left) and 5mC (right) across gene body ± 5 kb flanking regions with 200 bp resolution are shown.
(D) The normalized tag density profiles for 5hmC (left) and 5mC (right) around ± 5 kb regions flanking CpGI centers with 100 bp resolution are shown.
See also Figure S1 and Tables S1 and S2.factors. Tbx21 and Foxp3 were indeed associated with high
5hmC in Th1 and iTreg cells, respectively, implying regulation
of these genes by active DNA demethylation (Figure 2B). Espe-
cially, CNS2 in Foxp3 was intensely demethylated in iTreg cells.
This is consistent with a report on hypomethylation of CNS2 in
Foxp3 expression (Ohkura et al., 2012). However, prominent
5hmC peaks were located in Rorc and Gata3 in even non-
expressing cell lineages (Figure 2B). Thus, these observations
suggest that the expression of Gata3 and Rorc might not be
regulated by active DNA demethylation.
Collectively, our data prove that 5mC and 5hmC at lineage-
specific signature cytokine genes seem to correlate with their
expression in Th cell subsets and suggest that active DNAdeme-
thylation might be one important mechanism for gene regulation
during Th cell development.
5hmC Marks Transcriptional Regulatory Regions
Epigenetic control of gene expression involves dynamic regula-
tion of DNA methylation and histone modifications. Althoughseveral studies assessed the regulation of DNA methylation by
histone modification patterns (Cedar and Bergman, 2009), the
relationship between active DNA demethylation and histone
modification remain unclear. To correlate DNA demethylation
and histone modifications, we used published chromatin data
from Th cell subsets available in databases (Wei et al., 2009).
In silico analysis revealed that 5hmC peaks in Th-cell-specific
signature genes partly colocalized with H3K4me3 modification,
a histone marker associated with transcriptionally active state
(Figure S4A). These findings support previous reports that
5hmC is enriched in euchromatin in cerebellar cell types (Melle´n
et al., 2012) and that enhanced H3K4me3 appeared to be corre-
lated with CpG hypomethylation within the Treg-cell-associated
genes (Ohkura et al., 2012). Yet the overall picture of H3K4me3
distribution pattern seemed not to match that of the 5hmC distri-
bution pattern in each Th cell subset (Figure S4B). As previously
reported, the majority of H3K4me3 is enriched near TSSs (Wei
et al., 2009), whereas the majority of 5hmC is depleted from
TSSs (Figures 1 and S4B). In addition, we sought to calculateImmunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc. 615
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Figure 2. 5hmC and 5mC Modifications of Signature Cytokine Genes and Transcription Factor Genes in Th Cells
Distribution of 5hmC and 5mC in the Ifng (chr10: 117,810,000–117,940,000), Il4, Il13, Il5 (chr11: 53,420,500–53,553,500), Il17a, Il17f (chr1: 20,713,500–
20,787,300), Il10 (chr1: 132,884,100–132,923,100), (A) Tbx21 (chr11: 96,958,500–96,987,500), Gata3 (chr2: 9,777,000–9,802,000), Rorc (chr3: 94,175,000–
94,191,200), and Foxp3 (chrX: 7,153,000–7,170,500) (B) genomic regions in each T cell subset is shown. All figures with views of 5hmC and 5mC distribution are
labeled such that the arrow represents the direction of gene transcription. Gene structure is downloaded from the UCSC Genome Browser, and only tags on
islands are shown. The islands labeled in black represent 5hmC. The islands labeled in red represent 5mC. Scales are kept constant among cell types. Unique
peaks are highlighted by green squares. See also Figures S2 and S3 and Table S3.the total number of peaks that are overlapped between modifi-
cations. Expectedly, H3K4me3 preferentially overlapped with
5hmC rather than 5mC. However, only around 10% to 20% of
H3K4me3 sites were shared with 5hmC islands in each Th cell
subset (Figure S4C). Thus, generally speaking, a minority of
these two modifications was overlapped in each Th cell subset.
Collectively, although active DNA demethylation is correlated
with the enhancement of H3K4me3, this relationship seems
to be limited to certain regions of linage-specific signature
gene loci.
To further characterize whether 5hmC contributes to the
transcriptional regulation during Th cell differentiation, we then
analyzed whether 5hmC was colocalized with binding sites for
active enhancer-defining factor p300. The genome-wide p300
binding sites have been previously defined by Vahedi et al.
(2012) in Th1 cells as well as by Ciofani et al. (2012) in Th17 cells.
As shown in Figure 3A, 26%–34% of p300 binding sites colo-
calized with 9%–10% of 5hmC peaks in Th1 and Th17 cells,
whereas only 2%–8% of p300 binding sites colocalized with616 Immunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc.1%–4% of 5mC peaks in these cells. Taken together, our data
demonstrate a genome-wide enrichment of 5hmC modification
on the active enhancers in effector T cells.
Although our data indicated that 5hmC was depleted from
TSSs and proximal promoters as well as the centers of CpGIs,
we found that the binding sites of key transcription factors as
well as evolutionarily conserved enhancers marked by p300 co-
localized with 5hmC but not 5mC on lineage-specific signature
gene loci in Th1 and Th17 cells (Figure 3B). We therefore
explored the colocalization between 5hmC and binding sites of
key transcription factors governing Th1 and Th17 cell develop-
ment, particularly Stat4, T-bet, and Stat1 in Th1 cells (Vahedi
et al., 2012), as well as Stat3, RORgt, Batf, Irf4, and Maf (Ciofani
et al., 2012). As expected, 17%–26% of these transcription fac-
tor binding sites were localized at 5hmC-occupied genomic
regions, whereas only 1%–7% of them co-localized with 5mC
peaks (Figure 3A). Moreover, enrichment of 5hmC modification
was found on the binding sites of all tested transcription factors
(Figure 3A).
AB
Figure 3. Colocalization of 5hmC with
Active Enhancers Bound by p300 and Key
Transcription Factors in Th1 and Th17 Cells
(A) Top: the percentages of total p300 and tran-
scription factor binding sites colocalized with 5mC
(gray) and 5hmC (black) peaks was shown in Th1
and Th17 cells. Bottom: the percentages of 5mC
(gray) and 5hmC (black) peaks that were co-
localized with p300, Stat4, T-bet, and Stat1 bind-
ing sites in Th1 cells (left), as well as with p300,
Stat3, Rorc, Batf, Irf4, and Maf binding sites in
Th17 cells (right) is shown.
(B) Distribution of 5hmC, 5mC, p300, and tran-
scription factors binding sites along Ifng, Il17a, and
Il17f genomic region in Th1 (Stat4, T-bet, Stat1)
(left) and Th17 (Stat3, RORgt, Irf4, Maf, Batf) (right)
cells are shown. The regions of overlapping peaks
are highlighted by red squares.
See also Figure S4.Tet2 Recruitment to the Cytokine Genes Is Dependent
on Lineage-Specific Key Transcription Factors
Recently, it has been reported that proteins of Tet family (TET1,
TET2, and TET3) can regulate gene transcription by converting
5mC to 5hmC. As a first step to verify the role of Tet proteins in
Th cell development, we examined the mRNA expression of
Tet in each Th cell subset. Consistent with a previous report
(Ko et al., 2010), naive CD4+ T cells expressed all Tet family
members in high amounts (Figure 4A). Although the expression
of all Tet members was downregulated after TCR-mediated
activation, Tet2 was highly expressed in each Th cell subsetImmunity 42, 613–6compared to other Tet. This result led us
to a hypothesis that Tet2 might play a
crucial role in Th cell differentiation.
Because we have identified 5hmC-
associated regions, we analyzed whether
Tet2 is recruited to these loci in various
Th cell lineages by chromatin immunopre-
cipitation (ChIP) assay. As expected, in
Th1 cells, Tet2 was found recruited to
CNS(6) and promoter regions of the
Ifng locus that contain 5hmC, but not to
promoter region of H19 imprinted gene
(Figure 4B). Tet2 needs co-factor(s) for
binding to DNA, because it does not
have aCXXCDNAbindingdomain (Pastor
et al., 2013). Previously, one group re-
ported that T-bet was bound to CNS(6)
and promoter regions of the Ifng locus in
Th1 cells (Hatton et al., 2006). Therefore,
we decided to assess the role of T-bet in
Tet2 recruitment. According to hMeDIP
and ChIP analysis with Tbx21-deficient
T cells, 5hmC and Tet2 recruitment in
Ifng were reduced in Tbx21-deficient
Th1 cells (Figure 4B). Thus, these results
suggest that Tet2 induces DNA demethy-
lation at the Ifng locus in a T-bet-depen-
dent manner in Th1 cells.Similarly, we examined the recruitment of Tet2 to the Il17a and
Il17f loci in Th17 cells. We previously reported that the CNS2 re-
gion of the Il17a and Il17f loci is essential for the function of ROR
factors in Il17a expression (Wang et al., 2012). Therefore, we
examined the association of Tet2 in CNS2 and Il17a promoter
region. As shown in Figure 4C, Tet2 associated with CNS2
and Il17a promoter regions, which correlated with existence of
5hmC at these sites. Furthermore, 5hmC and Tet2 recruitment
were diminished in the absence of CNS2 region or RORgt
(Figure 4C), indicating that Tet2 induces DNA demethylation at
the Il17 locus in a RORgt-dependent manner in Th17 cells. In26, April 21, 2015 ª2015 Elsevier Inc. 617
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Figure 4. The Recruitment of Tet2 to the Signature Cytokine Gene Loci Is Dependent on Lineage-Specific Transcription Factors
(A) Naive T cells were cultured under differentiation conditions for each Th cell subset. Tet family mRNA expression was analyzed by real-time RT-PCR.
(B) Naive T cells fromWT and Tbx21/mice were cultured under Th1 cell conditions for 4 days. 5hmC (left) and Tet2 accessibility (right) in Ifngwere analyzed by
hMeDIP- and ChIP-PCR, respectively.
(C) Naive T cells from littermate control andCNS2/ orCD4CreRorcf/f mice were cultured under Th17 cell conditions for 4 days. 5hmC (left) and Tet2 accessibility
(right) in Il17 were analyzed by hMeDIP- and ChIP-PCR, respectively.
(D) Naive T cells from CD4CreSTAT3f/f and littermate control mice were cultured under Th17 cell conditions for 4 days. 5hmC (left) and Tet2 accessibility (right) in
Il10 were analyzed by hMeDIP- and ChIP-PCR, respectively.
The data represent the average of at least three independent experiments and shown as mean ± SD. See also Figure S5.contrast, although 5hmC peaks of lineage signature genes were
observed in Th2 and iTreg cells, we could not detect the strong
recruitment of Tet2 to these regions (Figures 2, S5A, and S5B).
A previous study indicated that Th17 cells produce IL-10 in a
STAT3-dependent manner (Stumhofer et al., 2007). Therefore,
we also analyzed the Il10 locus under the Th17 cell condition
by use of STAT3-deficient T cells or their controls. Tet2 was
found recruited to the CNS2 region of the Il10 locus, which con-
tained 5hmC, in a manner dependent on STAT3 (Figure 4D).
Collectively, these results suggest that Tet2 induces active
DNA demethylation of signature cytokine genes in a particular
Th cell subset and that its action is dependent on lineage-spe-
cific transcription factors.
Tet2 Regulates Th1 and Th17 Cell Differentiation
The above analysis has suggested 5hmC and Tet2 in Th cell
differentiation. To further assess the role of Tet2 in Th cells, we
analyzed the differentiation of each Th cell subset by using
Tet2-deficient (Tet2/) CD4+ T cells derived from Cd2CreTet2f/f
mice (Moran-Crusio et al., 2011) in vitro. In accordance with pre-618 Immunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc.vious reports (Ko et al., 2011), Cd2CreTet2f/f mice had normal
development of CD4+ and CD8+ T cells and B cells (data not
shown). In support of Figures S5A and S5B, both intracellular
staining and qPCR analysis revealed that the differentiation of
Th2 and iTreg cells were not affected in Tet2/ T cells (Figures
S5C–S5E, S5G, and S5H). Additionally, 5hmCmarks in signature
genes were similar between Tet2+/+ and Tet2/ T cells (Figures
S5F and S5I). In contrast, deletion of Tet2 led to 80%–83%
reduction in genome-wide 5hmC peaks in Th1 and Th17 cells
(Figure S6A). Most of the 20% residual 5hmC peaks in Tet2/
cells existed in wild-type Th1 and Th17 cells, suggesting that in
addition to Tet2, other Tet family membersmight also be respon-
sible for maintaining the DNA demethylation process in Th1 and
Th17 cells.We also analyzed the general difference in tag density
of 5hmC around gene promoters, CpGIs, as well as all 5hmC
sites that appeared in wild-type Th cells. As shown in Figure S6A,
the depletion of 5hmC around TSSs and CpGIs was only slightly
reduced in Tet2-deficient Th1 cells. However, the depletion of
5hmC in TSSs and CpGIs in WT Th17 cells was totally reversed
in Tet2-deficient Th17 cells. Moreover, the reduction of 5hmC
A B
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Figure 5. Tet2 Is Important for Th1 Cell Differentiation In Vitro
(A) Top: intracellular cytokine staining after 5 days of Th1 cell differentiation from Tet2f/f and Cd2CreTet2f/f mice. Data are representative of at least three individual
experiments. Bottom: the expression of Ifng and Tbx21 mRNA by Tet2f/f and Cd2CreTet2f/f Th1 cells.
(B and C) The hMeDIP (B) and ChIP (C) on Ifng were performed in Th1 cells from Tet2f/f and Cd2CreTet2f/f mice.
(D) Microarray analysis comparing Tet2+/+ versus Tet2/ Th1 cells. The bar graph showed representative genes. Venn diagram showing the number of 5hmC-
containing genes affected or unaffected by Tet2 deficiency. 5hmC-containing genes were identified if at least one peak of a-5hmC binding was present on their
promoter plus gene body regions (3K to TTS).
(E and F) The ChIP of Ifng was performed in Th1 cells from Tet2f/f and Cd2CreTet2f/f mice.
(A–C, E, F) The data represent the average of at least three independent experiments. All the data are shown as mean ± SD. See also Figures S5 and S6 and
Table S4.tag density as a result of Tet2 deficiency was more profound in
Th17 cells than in Th1 cells, suggesting that Tet2 deficiency
might have more global effect on Th17 cells than on Th1 cells.
Under Th1 cell polarization condition, Tet2/ T cells showed a
marked reduction in IFN-g at mRNA and protein levels, but
Tbx21 expression and cell proliferation were not affected (Fig-
ures 5A and S6B–S6D). Furthermore, 5hmC marks in Ifng were
decreased by Tet2 deficiency in Th1 cells (Figure 5B). In contrast,we found that 5hmC status in Tbx21 was not changed by Tet2
deficiency (Figure S6E). Moreover, Tet2 did not bind to this re-
gion in Th1 cells (Figure S6F), suggesting the involvement of
other Tet family proteins. The recruitment of T-bet in Ifng was
also substantially decreased by Tet2 deficiency in Th1 cells (Fig-
ure 5C). Because Tet2 recruitment to the Ifng locus is dependent
on T-bet (Figure 4B), Tet2 and T-bet might reciprocally regulate
the function of each other in Ifng expression. To globally identifyImmunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc. 619
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Figure 6. Tet2 Controls Th17 Cell Development In Vitro
(A) Left: intracellular cytokine staining after 4 days of Th17 cell differentiation from Tet2f/f andCd2CreTet2f/f mice. Data are representative of at least three individual
experiments. Right: the expression of Il17a, Il17f, and Rorc mRNA in Th17 cells from Tet2f/f and Cd2CreTet2f/f mice.
(B and C) The MeDIP (B) and ChIP (C) on Il17 were performed in Th17 cells from Tet2f/f and Cd2CreTet2f/f mice.
(D) Microarray analysis comparing Tet2+/+ versus Tet2/ Th17 cells. The bar graph shows representative genes. Venn diagram showing the number of 5hmC-
containing genes affected or unaffected by Tet2 deficiency. 5hmC-containing genes were identified if at least one peak of a-5hmC binding was present on their
promoter plus gene body regions (3K to TTS).
(E and F) The ChIP of Il17 was performed in Th17 cells from Tet2f/f and Cd2CreTet2f/f mice.
(legend continued on next page)
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the target genes of Tet2 in Th1 cells, we next performed DNA
microarray analysis by using Tet2+/+ and Tet2/ Th1 cells.
Tet2 target genes were then identified based on microarray
and hMeDIP-seq data. A 1.5-fold change (WT versus KO) was
used as a cutoff for significance. Although a total of 229 Th1-
cell-specific genes (genes expressed at least 2-fold higher in
Th1 than Th17 cells) had 5hmC in Th1 cells, surprisingly, only
the expression of Ifng, Il3, and Prdm1 were changed due to
Tet2 deficiency (1.3%, 3/229) (Figure 5D). On the other hand,
we found 51 genes with at least 1.5-fold difference in gene
expression between Tet2+/+ and Tet2/ Th1 cells, 26 of which
have 5hmC peaks on their promoters and/or gene bodies (Table
S4), suggesting that Tet2 might regulate the expression of genes
without 5hmC modification.
As mentioned above, 5hmC partly correlates with H3K4me3
(Figure S4). Recently, it has been reported that Tet2 facilitates
GlcNAcylation and H3K4 methylation (Deplus et al., 2013).
Therefore, to clarify whether Tet2 regulates the chromatin modi-
fication in Th cells, we analyzed H3Ac, H3K4me3, and
H3K27me3 modifications at Ifng in Tet2/ Th1 cells by ChIP
assay. As shown in Figure 5E, in CNS(6) and Ifng promoter re-
gions, permissive histone markers H3Ac and H3K4me3 were
modestly reduced in Tet2/ Th1 cells. Additionally, to further
understand how Tet2 might regulate chromatin accessibility,
we also evaluated the recruitment of p300 to the Ifng locus.
The deficiency of Tet2 resulted inmarked inhibition of the binding
of p300 to CNS(6) and the promoter region of Ifng (Figure 5F).
Next, we sought to examine the role of Tet2 in Th17 cells in the
samemanner. Under Th17 cell differentiation conditions, Tet2/
T cells showed amarked suppression in IL-17mRNA and protein
expression compared to Tet2+/+ T cells, but the expression of
IL-17F, IL-2, and RORgt as well as cell expansion were normal
(Figures 6A and S6G–S6I). In addition, we examined the effect
of Tet2 on 5hmC peaks and RORgt recruitment in the Il17 locus.
As expected, the deficiency of Tet2 led to a reduction of 5hmC
and RORgt binding at CNS2 and Il17a promoter regions in Th17
cells (Figures 6B and 6C), implying a reciprocal regulation of
Tet2 andRORgt function in Il17a expression. To assess the target
genes of Tet2 in Th17 cells, we also performed microarray anal-
ysis with Tet2+/+ and Tet2/ Th17 cells. Based on the analysis
of microarray and MeDIP-seq results, only six genes (Ccl20,
Il10,Gpr83,Emp1,Rbl2, and Il17a) were found as Tet2-regulated
genes froma total of 197 Th17-cell-specific genes (genes that are
expressed at least 2-fold higher in Th17 thanTh1 cells) with 5hmC
in Th17 cells (3%, 6/197) (Figure 6D). Similar to the finding in Th1
cells, about 50%of geneswith at least 1.5-fold difference in gene
expression between Tet2+/+ and Tet2/ Th17 cells had 5hmC
peaks on their promoter and/or gene body regions (Table S4).
To evaluate the effect of Tet2 on chromatin remodeling at Il17
locus, we examined histone modifications and p300 recruitment
inTet2/Th17 cells. As shown in Figure 6E,H3Ac andH3K4me3
were reduced in Tet2/ Th17 cells along with increased
repressive histone marker H3K27me3 at CNS2 and Il17a pro-(G) Left: ELISA analysis of supernatants from Th17 cell differentiation on day 4. All
cells from Tet2f/f and Cd2CreTet2f/f mice. Right: a hMeDIP of Il10 and H19 loci w
(H and I) The ChIP of Il10 was performed in Th17 cells from Tet2f/f and Cd2CreTe
(A–C, E–I) The data represent the average of at least three independent experimmoter. Importantly, the deficiency of Tet2 led to considerable in-
hibition in binding of p300 to CNS2 and Il17a promoter regions
(Figure 6F).
Microarray and hMeDIP-seq analysis suggested that Tet2 reg-
ulates IL-10 production in Th17 cells. Indeed, under Th17 cell
conditions, Tet2/ T cells displayed a considerable repression
of IL-10 production compared with Tet2+/+ T cells (Figure 6G).
In addition, we also evaluated 5hmC status of Il10 in Tet2/
T cells. As expected, the ablation of Tet2 resulted in a reduction
of 5hmCat theCNS2 region but not the Il10 promoter (Figure 6G).
To elucidate the impact of Tet2 on the chromatin structure of the
Il10 locus, we analyzed histone modifications and p300 recruit-
ment in the CNS2 region of Il10 in Tet2/ Th17 cells. H3Ac
and H3K4me3 marks as well as p300 recruitment were dimin-
ished in the absence of Tet2 (Figures 6H and 6I). As previously
reported (Ouyang et al., 2011), IL-10-producing IFN-g+ Th1 cells
are present in a variety of infections and they play an important
task of protecting against severe immune-mediated pathology.
Therefore, we also assessed the role of Tet2 in IL-10 production
from Th1 cells. Similar to Th17 cells, the induction of IL-10 and
5hmC in the CNS2 region of Il10 was strongly abrogated by
Tet2 deficiency in Th1 cells (data not shown).
Collectively, our results demonstrate that Tet2 promotes the
development of Th1 and Th17 cells by regulating specifically
the expression of signature cytokines through active DNA deme-
thylation and that its deficiency had some effect on chromatin
remodeling, especially p300 recruitment to the target genes.
Tet2 Controls IL-10, IFN-g, and IL-17 Production in
Autoimmunity
To examine whether Tet2 is critical for Th cell differentiation
in vivo, we first immunized mice with MOG35-55 peptide and
analyzed the spleens of Tet2f/f and Cd2CreTet2f/f mice on day 7.
Similar to in vitro results, we found that the MOG-specific
production of IFN-g and IL-10 were decreased in Cd2CreTet2f/f
mice (FigureS7A). Therewasnoor slight difference in theproduc-
tion of MOG-specific IL-17F and IL-2 between Tet2f/f and
Cd2CreTet2f/f mice (data not shown). However, in contrast to
in vitro results, the production of MOG-specific IL-17 was com-
parable between Tet2f/f and Cd2CreTet2f/f mice (Figure S7A). It
has been known that IL-10 plays a critical role in suppressing
autoimmunity and inflammatory responses. A previous study
demonstrated that IL-10 produced by Th17 cells restrains the
pathologic effects of Th17 cells (McGeachy et al., 2007). There-
fore, to clarify whether the unexpected high production of IL-17
in Cd2CreTet2f/f mice was caused by the reduced IL-10 produc-
tion, we treatedmicewith IL-10 receptor 1-specific blocking anti-
body (a-IL-10RAb). After treatingwith a-IL-10RAb,Cd2CreTet2f/f
mice showed a marked reduction of MOG-specific IL-17 and
IFN-g production (Figure 7A), implying that Tet2 plays a similar
role in Th1 and Th17 cell differentiation in vitro and in vivo.
To further address the function of Tet2 in autoimmune re-
sponses, both Tet2f/f and Cd2CreTet2f/f mice were subjected togroups were analyzed in triplicate. Middle: the expression of Il10mRNA in Th17
as performed in Th17 cells from Tet2f/f and Cd2CreTet2f/f mice.
t2f/f mice.
ents. All the data are shown as mean ± SD. See also Figure S6 and Table S4.
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Figure 7. Tet2 Regulates Cytokine Production in Autoimmunity
(legend continued on next page)
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MOGpeptide-induced experimental autoimmune encephalomy-
elitis (EAE), a mouse model for human multiple sclerosis (Baxter,
2007). The severity of EAE diseases was enhanced in Tet2-defi-
cient mice (Figure S7B). The frequency and absolute number of
IL-17+ T cells in the central nervous system on day 13 after the
second immunization were strongly elevated in Cd2CreTet2f/f
mice, whereas the frequencies and absolute numbers of IFN-
g+, IFN-g+IL-17+, IL-10+, and IL-10+IL-17+ T cells in the central
nervous system were decreased in Cd2CreTet2f/f mice (Figures
S7C and S7D). In agreement with in vitro findings, the frequency
and absolute number of Foxp3+ T cells in the central nervous
system were similar between Tet2f/f and Cd2CreTet2f/f mice (Fig-
ure S7D). The Cd2Cre transgenic mice are useful for generating
conditional mutations not only in T cells but also in B cells (de
Boer et al., 2003). To confirm the CD4+ T-cell-intrinsic function
of Tet2 in vivo, we transferred Tet2f/f or Cd2CreTet2f/f CD4+
T cells into Rag1/ mice and immunized them with MOG pep-
tide. The mice transferred with Tet2f/f CD4+ T cells developed
disease score around 2.0, whereas the mice transferred with
Cd2CreTet2f/f CD4+ T cells had more severe symptoms (score
around 3.0) (Figure 7B). The frequencies of IFN-g+, IFN-g+IL-
17+, and IL-10+ T cells in the central nervous system on day 14
after the second immunization, but not IL-17+ and Foxp3+
T cells, were much lower in the mice that received Cd2CreTet2f/f
CD4+ T cells than Tet2f/f CD4+ T cells (Figure 7C). Furthermore,
we found that a marked reduction of IFN-g and IL-10 secretion,
but not IL-17, were also observed by ELISA assays in the spleno-
cytes ofmice that receivedCd2CreTet2f/f CD4+ T cells (Figure 7D).
These results indicate that Tet2 expression in CD4+ T cells plays
an important role in the suppression of disease severity of EAE.
To address the mechanism whereby Tet2 restrains the dis-
ease severity in EAE, we did EAE experiments in Tet2f/f and
Cd2CreTet2f/f mice with a-IL-10R Ab treatment at every 4 days
during EAE. As a result of the treatment, the severity of EAE dis-
eases was reduced in a-IL-10R Ab-treated Cd2CreTet2f/f mice
(Figure 7E). The enhancement of IL-17+ T cells in Cd2CreTet2f/f
mice was abolished by neutralization of IL-10 (Figure 7F).
Furthermore, the frequencies and absolute numbers of IFN-g+
and IFN-g+IL-17+ T cells but not Foxp3+ and IL-10+ T cells in
the central nervous system on day 11 after the second immuni-
zation were decreased in a-IL-10R Ab-treated Cd2CreTet2f/f
mice (Figure 7F). In addition, the strong reduction of IFN-g and(A) Age-matched Tet2f/f and Cd2CreTet2f/f mice (n = 4) were immunized with MOG
production. For neutralization of IL-10, a-IL-10R or a-Rat IgG1 was intraperitonea
experiments.
(B)Rag1-deficient mice were reconstituted with CD4+ T cells derived from Tet2f/f a
with MOG35-55.
(C) Left: IL-17, IFN-g, and IL-10 were determined in the infiltrates of central nerv
(D) IL-17, IFN-g, and IL-10 were measured by ELISA in the splenocytes of
peptide (mg/ml).
(E) Age-matched Tet2f/f andCd2CreTet2f/f mice were immunized twice withMOG35
administered intraperitoneally every 4 days after immunization. Shown here is th
mice used: WT = 8, KO = 10).
(F) Left: IL-17 and IFN-g were determined in the infiltrates of central nervous sy
absolute number.
(G) IL-17, IFN-g, and IL-10 weremeasured by ELISA in the splenocytes of immuniz
peptide (mg/ml). Data are representative of at least two individual experiments.
All the data are shown as mean ± SD. See also Figure S7.IL-17 secretion was also observed in splenocytes of a-IL-10R
Ab-treated Cd2CreTet2f/f mice (Figure 7G).
Taken together, we conclude that Tet2 plays an important role
in regulating the expression of IL-10, IL-17, and IFN-g in vivo and
in regulating T-cell-mediated autoimmune diseases.
DISCUSSION
Epigenetic mechanisms have been proposed to regulate the
specification and plasticity of Th cell lineages (Wei et al., 2009).
Active DNA demethylation by Tet proteins has been recently
identified with critical roles in many physiological processes.
Here we provide evidence that 5hmC and Tet2 play important
roles in T cell function, particularly cytokine expression.
In this study, we first generated genome-wide maps of 5mC
and 5hmC modifications in Th cell subsets differentiated
in vitro by use of high-throughput DIP-seq approach. Consistent
with other studies (Tsagaratou et al., 2014), we found that 5hmC
is enriched in gene body and enhancer regions. However, a
decrease of the overall amount of 5hmC was found when naive
CD4+ T cells differentiated into effector cells. 5hmC cannot be
recognized by DNMT1, and therefore cannot be maintained dur-
ing DNA replication and cell proliferation (Valinluck and Sowers,
2007). A proliferation-dependent passive DNA demethylation,
suggested by the decrease of 5hmC during differentiation of
naive CD4+ T cells into effectors, might be crucial for the relief
of methylation-dependent transcriptional repression in naive
T cells. More interestingly, the lineage-specific cytokine as well
as some of the master transcription factors were tightly regu-
lated by DNAmethylation in naive T cells. The repression of these
genes’ expression by 5mC was removed only in the lineage
specified by the factors, but was maintained in other lineages,
strongly suggesting that the transition from 5mC to 5hmC was
an active (replication-independent) DNA demethylation process.
It is unclear whether DNA demethylation-dependent gene
regulation is controlled by lineage-defining transcription factors.
Our data suggest that a proportion of key transcription factor as
well as p300 binding sites co-localize with 5hmC but not 5mC in
Th1 and Th17 cells, as well as Th2 cells, but not iTreg cells (data
not shown). More importantly, the recruitment of Tet2 as well as
DNA demethylation is dependent upon key transcription factors
such as T-bet, RORgt, and Stat3, indicating a critical role of35-55 peptides on day 0 and then analyzed on day 7 for IL-17, IFN-g, and IL-10
lly injected on day 0 and day 4. Data are representative of at least two individual
ndCd2CreTet2f/f mice. Clinical scores weremonitored daily after EAE induction
ous system of immunized mice. Right: statistic of the frequency.
immunized mice, after restimulation with indicated concentration of MOG
-55. For neutralization of IL-10, 500 mg a-IL-10R or isotype control antibody was
e combinational result of two individual EAE experiments (the total number of
stem of immunized mice with a-IL-10R. Right: statistic of the frequency and
edmice with a-IL-10R, after restimulationwith indicated concentration of MOG
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these transcription factors in the active DNA demethylation and
chromatin restructuring process during T cell differentiation.
Although the regulation of gene expression by Tet2 seems to
be gene specific, the molecular mechanism by which these tran-
scription factors control gene-specific recruitment of Tet2 re-
mains to be determined. The key transcription factors for Treg
cells does not colocalize with 5hmC or 5mC (data not shown),
suggesting a differential mechanism by which iTreg cells are
epigenetically regulated at the methylation level.
Increasing evidence suggests that DNA methylation is inti-
mately linked to histone modifications. However, precisely how
Tet-mediated DNA demethylation and chromatin modifications
cooperatively contribute to gene expression has not yet been
clearly defined. Here, the integrative analysis of our DIP-seq re-
sults and published histone modification data indicated that
5hmC and H3K4me3 modifications were partly colocalized at
the regulatory elements of signature genes in Th cells. In support
of our findings, recent studies reported that 5hmC and Tet
proteins are enriched in euchromatin (Melle´n et al., 2012;
Deplus et al., 2013). In addition, we found that Tet2 deficiency
decreased the recruitment of p300 to promoters and enhancer
regions. These results suggest possible regulation of chromatin
configuration by Tet proteins.
Our genome-wide analysis revealed a 80%–83% reduction of
5hmCmodification in Tet2/ Th1 and Th17 cells as compared to
control, suggesting that in addition to signature cytokines, Tet2
might also control 5hmC on many other loci across the whole
genome in Th1 and Th17 cells. In contrast, about 20% 5hmC
were not affectedbyTet2 deficiency. Thus, other Tet familymem-
bers might control demethylation process on these loci in Th1
and Th17 cells. Indeed, despite the possession of lineage-spe-
cific 5hmC, Tbx21 in Th1 cells and IL-17F in Th17 cells were un-
affected by Tet2 depletion. Furthermore, the integrated analysis
of microarray and hMeDIP-seq data indicated that the vast ma-
jority of expressed genes bearing 5hmC in Th1 and Th17 cells
are not affected by Tet2 deficiency in vitro. In addition, we found
that the alteration in cytokine expression in Tet2-deficient cells
was partial. These results led to a hypothesis that Tet2 function
might be compensated by other Tet family members. Moreover,
we also found that Tet2 deficiency did not affect Th2 and iTreg
cell differentiation or 5hmC peaks on their signature genes.
Thus, further assessment with genetically modified mice of other
Tet proteins might yield additional insight into the roles of Tet-
mediated active DNA demethylation in Th cell differentiation.
Among all genes with at least 1.5-fold differences in their
expression between Tet2+/+ and Tet2/ Th1 and Th17 cells,
50% of them do not have 5hmC peaks associated with their
proximal promoters and gene body. Therefore, these results
suggest that Tet2 might regulate these genes indirectly. Alterna-
tively, several reports recently demonstrated that 5hmC could be
further oxidized to 5-formylcytosine (5fC) and 5-carboxylcyto-
sine (5caC) by Tet proteins (Pastor et al., 2013). Moreover, active
DNA demethylation pathways through these modifications have
actually been shown in mESCs (Pastor et al., 2013). Therefore,
we do not exclude the possibility that 5hmC in these genesmight
already be oxidized to 5fC/5caC. The roles of these oxidants in
Th cell differentiation will need to be studied.
We observed that Tet2-mediated active DNA demethylation
controls cytokines production in vivo. Importantly, IL-10 produc-624 Immunity 42, 613–626, April 21, 2015 ª2015 Elsevier Inc.tion from CD4+ T cells by Tet2 plays a crucial role in prevention
of excessive inflammation in EAE. Type 1 regulatory T (Tr1) cells
predominantly produce IL-10 and are differentiated by IL-27 and
TGF-b (Awasthi et al., 2007). We found that development of Tr1
cells, which express IFN-g and IL-10, were inhibited in the
absence of Tet2 (data not shown), suggesting that Tet2 plays a
crucial role in Tr1 cell development. Although the source of
IL-10 production among Th cell subsets in vivo remains to be
elucidated, several papers have proposed that IL-10 from Th1,
Tr1, and Th17 cells play a crucial role in limiting the pathologic
effects of Th17 cells during EAE (Ouyang et al., 2011). Therefore,
we believe that Tet2-mediated IL-10 production from Th1, Tr1,
and Th17 cells is a keymechanism for prevention from exacerba-
tion of EAE symptoms.
In summary, our results not only provide a global view of a
novel epigenetic modification that occurs during Th cell differen-
tiation, but also uncover a functional role for Tet2-mediated
active DNA demethylation in the function of Th cells both
in vitro and in vivo. Further assessment of TET proteins and
5mC oxidants will advance our understanding of the molecular
mechanisms underlying dynamic changes of DNA methylation
in T cell development and will provide new therapeutic targets
for innovative treatments of autoimmune diseases.
EXPERIMENTAL PROCEDURES
Mice
Cd2CreTet2f/f mice have been described previously (Moran-Crusio et al., 2011).
Cd2CreTet2f/f mice and wild-type littermates on the mixed background were
used in experiments. CD4CreRorcf/f mice and Il17fCre mice were generated in
our lab (unpublished data). Il17fCre mice and Rosa26yfp mice were crossed
to generate Il17fCreRosayfp mice. Ifngyfp mice were generously provided
by R.M. Locksley (University of California, San Francisco). C57BL/6 mice,
Tbx21/ mice (on the B6 background), Il4gfp mice, Rosa26yfp mice, and
Rag1/ mice (on the B6 background) were from the Jackson Laboratory.
All the mice were housed in the SPF animal facility at the M.D. Anderson
Cancer Center and the animal experiments were performed at the age of
6–12 weeks with the use of protocols approved by the Institutional Animal
Care and Use Committee.
Naive T Cell Preparation and Differentiation
Naive T cells were isolated by sorting CD4+CD25CD62LhiCD44lo cells from
spleens and lymph nodes, differentiated under several Th cell conditions,
and analyzed as described (Yang et al., 2008). The naive T cells (5 3 105
cells/well) were stimulated with the plate-bound a-CD3 (1 mg/ml) and the sol-
uble a-CD28 (1 mg/ml). For Th0 cell differentiation, the cells were treated with
5 mg/ml a-IFN-g (XMG1.2; BioXCell), 5 mg/ml a-IL-4 (11B11; BioXCell), and
30 U/ml IL-2. For Th1 cell differentiation, the cells were treated with 10 ng/
ml mIL-12 (Peprotech), 5 mg/ml a-IL-4, and 30 U/ml IL-2. For Th2 cell differ-
entiation, the cells were treated with 10 ng/ml mIL-4 (Peprotech), 5 mg/ml
a-IFN-g. For iTreg cell differentiation, the cells were treated with 1 ng/ml
TGF-b1 (Peprotech), 5 mg/ml a-IFN-g, 5 mg/ml a-IL-4, and 30 U/ml IL-2. For
Th17 cell differentiation, the cells were treated with 0.5 ng/ml TGF-b1,
10 ng/ml IL-6 (Peprotech), 5 mg/ml a-IFN-g, and 5 mg/ml a-IL-4. When indi-
cated, 10 ng/ml IL-23 and 10 ng/ml IL-1b (Peprotech) were used for optimal
Th17 cell differentiation.
DIP Sequencing and Data Analysis
The genomic DNA was purified and sonicated. DNA fragments (4 mg) were de-
natured and incubated with antibody against 5mC (Eurogentec), 5hmC (Active
Motif), or control IgG at 4Covernight. The IPed DNA fragments were prepared
with Dynabeads Protein G (Life Technologies) and amplified with the Illumina
ChIP-seq DNA preparation kit (IP-202-1012) and sequenced on the Illumina
GA II and HiSeq2500 sequencing platforms.
The unique reads for 5mC and 5hmC were mapped into non-overlapping
200 bp windows of mouse genome (mm9). The peaks were called with SICER
(Zang et al., 2009), with the Input DNA sample as a control and a FDR of 0.01 as
the cutoff. To determine whether the sequencing depth was enough to cover
5mC and 5hmC libraries, we carried out a scaling analysis. The number of
peaks identified from a fraction of randomly sampled reads in each library
via SICER was plotted. An estimation of the total reads beyond which no
more peaks would be identified was determined. To calculate the tag density
of 5mC and 5hmC, the number of reads was first summed in 5-bp or 100-bp
windows within the regions of 5 kb upstream and downstream of TSSs or
CpGIs or within the regions of 2 kb upstream and downstream of the centers
of all p300/TF binding sites. All tag counts were then normalized by the total
number of bases within the windows and the total number of reads in the given
library.
Statistical Analysis
The statistical significance was determined by Student’s paired two-tailed
t test (*p < 0.05; **p < 0.01; ***p < 0.005). All error bars shown in this article
represent SDs.
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Note Added in Proof
Since the submission of this manuscript, an additional paper has demon-
strated dynamic changes in 5hmC during Th1 and Th2 cell differentiation
and thymic T cell development. This includes the following:
Tsagaratou, A., A¨ijo¨, T., Lio, C.W., Yue, X., Huang, Y., Jacobsen, S.E., La¨hdes-
ma¨ki, H., andRao, A. (2014). Dissecting the dynamic changes of 5-hydroxyme-
thylcytosine in T-cell development and differentiation. Proc. Natl. Acad. Sci.
USA. 111, E3306–E3315.
